Stuck on an FDA Import Alert?
Let’s Get You Off the List.
TFacing an FDA Import Alert can halt your shipments and drain your revenue. When your drug product is flagged, Detention Without Physical Examination (DWPE) results in automatic holds at U.S. ports, leaving no way forward without immediate corrective action.
Registrar Corp helps pharmaceutical companies navigate FDA challenges with precision. Our experts prepare compliant petitions, guide corrective actions, and accelerate product re-entry into the U.S. market.

3,000+ Drug Manufacturers Trust Registrar Corp









What is an FDA Import Alert or DWPE?

FDA issues Import Alerts to stop products suspected of violating US. regulations from entering the country. When under DWPE, your shipments may be detained without inspection often due to past violations, labeling issues, or facility concerns.
Common Causes include:
- Misbranding or improper labeling
- Presence of unapproved drugs or ingredients
- Recurring product non-compliance
- Lack of prior approval or registration
- cGM P (Good Manufacturing Practice) violations
If you’re on an FDA Import Alert, your shipments won’t move without proving compliance.
How Registrar Corp Helps
We guide you through every step of addressing and resolving import detentions:
Why Choose Registrar Corp?
24/7 support for urgent
detention or refusal
cases
Over 30,000 clients
served in 160+
countries
Regulatory experts with
FDA communication
experience
End-to-end service
from root cause
to reinstatement
Decades of experience
across drug, food, medical
device, and cosmetic
sectors
Contact Us
"*" indicates required fields